Compare
Molina Healthcare, Inc. vs Humana Inc vs Oscar Health, Inc. vs Centene Corp
| Latest fiscal year | Molina Healthcare, Inc. MOH | Humana Inc HUM | Oscar Health, Inc. OSCR | Centene Corp CNC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $45.43B | $129.66B | $11.70B | $194.78B |
| Revenue growth (YoY) | +11.7% | +10.1% | +27.5% | +19.4% |
| Gross margin | n/a | n/a | n/a | 7.3% |
| Operating margin | 1.7% | 2.1% | -3.4% | -3.9% |
| Net margin | 1.0% | 0.9% | -3.8% | -3.4% |
| Net income | $472.00M | $1.19B | -$443.15M | -$6.67B |
| EPS (Diluted) | $8.92 | $9.84 | -$1.69 | -$13.53 |
| Operating cash flow | -$535.00M | $921.00M | $1.09B | $5.09B |
| Free cash flow | -$636.00M | $375.00M | $1.06B | $4.32B |
| Cash & equivalents | $4.25B | $4.20B | $2.77B | $17.89B |
| Total assets | $15.56B | $48.91B | $6.33B | $76.75B |
| Total liabilities | $11.49B | $31.17B | $5.34B | $56.69B |
| Shareholders' equity | $4.07B | $17.66B | $980.74M | $20.03B |
| Return on year-end equity | 11.6% | 6.7% | -45.2% | -33.3% |
| Shares outstanding | 51.00M | n/a | n/a | 491.76M |
Revenue, most recent five fiscal years
| Fiscal year | Molina Healthcare, Inc. | Humana Inc | Oscar Health, Inc. | Centene Corp |
|---|---|---|---|---|
| Latest | $45.43B Ended 2025-12-31 | $129.66B Ended 2025-12-31 | $11.70B Ended 2025-12-31 | $194.78B Ended 2025-12-31 |
| 1 year earlier | $40.65B Ended 2024-12-31 | $117.76B Ended 2024-12-31 | $9.18B Ended 2024-12-31 | $163.07B Ended 2024-12-31 |
| 2 years earlier | $34.07B Ended 2023-12-31 | $106.37B Ended 2023-12-31 | $5.86B Ended 2023-12-31 | $154.00B Ended 2023-12-31 |
| 3 years earlier | $31.97B Ended 2022-12-31 | $92.87B Ended 2022-12-31 | $3.96B Ended 2022-12-31 | $144.55B Ended 2022-12-31 |
| 4 years earlier | $27.77B Ended 2021-12-31 | $83.06B Ended 2021-12-31 | $1.84B Ended 2021-12-31 | $125.98B Ended 2021-12-31 |